Home
CLYM
CLYM News

Latest CLIMB BIO INC (CLYM) News on January 22, 2025

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

GlobeNewswire

13 days ago

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

Climb Bio to be Added to the Nasdaq Biotechnology Index

GlobeNewswire

a month ago

Climb Bio to be Added to the Nasdaq Biotechnology Index

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

2 months ago

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

GlobeNewswire

2 months ago

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

Climb Bio to Present at Upcoming Investor Conferences

GlobeNewswire

3 months ago

Climb Bio to Present at Upcoming Investor Conferences

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

GlobeNewswire

3 months ago

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

GlobeNewswire

3 months ago

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

GlobeNewswire

4 months ago

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

Share on Social Networks: